CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. (1st November 2018)
- Record Type:
- Journal Article
- Title:
- CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. (1st November 2018)
- Main Title:
- CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells
- Authors:
- Lopes, Rui
Korkmaz, Gozde
Revilla, Sonia Aristin
van Vliet, Romy
Nagel, Remco
Custers, Lars
Kim, Yongsoo
van Breugel, Pieter C.
Zwart, Wilbert
Moumbeini, Behzad
Manber, Zohar
Elkon, Ran
Agami, Reuven - Abstract:
- Abstract: Breast cancer is the most prevalent type of malignancy in women with ∼1.7 million new cases diagnosed annually, of which the majority express ERα (ESR1), a ligand-dependent transcription factor. Genome-wide chromatin binding maps suggest that ERα may control the expression of thousands of genes, posing a great challenge in identifying functional targets. Recently, we developed a CRISPR-Cas9 functional genetic screening approach to identify enhancers required for ERα-positive breast cancer cell proliferation. We validated several candidates, including CUTE, a putative ERα-responsive enhancer located in the first intron of CUEDC1 (CUE-domain containing protein). Here, we show that CUTE controls CUEDC1 expression, and that this interaction is essential for ERα-mediated cell proliferation. Moreover, ectopic expression of CUEDC1, but not a CUE-domain mutant, rescues the defects in CUTE activity. Finally, CUEDC1 expression correlates positively with ERα in breast cancer. Thus, CUEDC1 is a functional target gene of ERα and is required for breast cancer cell proliferation. Highlights: CUTE (CU EDC1 T ranscriptional E nhancer) is a putative ERα-responsive enhancer located in the first intron of CUEDC1 . CUTE controls CUEDC1 expression, and that this interaction is essential for ERα-mediated proliferation. Activation of CUEDC1 is essential for ERα-mediated stimulation of cellular proliferation. CUEDC1 expression correlates with ERα in breast cancer.
- Is Part Of:
- Cancer letters. Volume 436(2018)
- Journal:
- Cancer letters
- Issue:
- Volume 436(2018)
- Issue Display:
- Volume 436, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 436
- Issue:
- 2018
- Issue Sort Value:
- 2018-0436-2018-0000
- Page Start:
- 87
- Page End:
- 95
- Publication Date:
- 2018-11-01
- Subjects:
- Cancer -- Enhancer -- Breast -- CRISPR-Cas9
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2018.08.018 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23120.xml